Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BDSA is a leading market intelligence and data analytics firm dedicated to the global cannabinoid industry. The company provides a comprehensive suite of tools, including retail sales tracking, consumer insights, and market forecasting, to help businesses navigate the complex legal cannabis and hemp sectors. By aggregating granular data from point-of-sale systems and conducting extensive consumer surveys, BDSA enables pharmaceutical, consumer packaged goods (CPG), and healthcare companies to identify market trends, optimize product portfolios, and understand patient behavior. Their platform is a critical resource for stakeholders seeking data-driven strategies in the rapidly evolving medical and adult-use cannabis markets. Often referred to as the Nielsen of Cannabis, BDSA offers the most detailed insights into product performance, pricing, and consumer demographics across various jurisdictions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BDSA.